04.05.2024 |
Identifying Biomarkers for Visual Restoration Strategies in NF1-OPGs
04.05.2024 |
A Phase 3 Randomized Study of Selumetinib versus Carboplatin and Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
04.05.2024 |
Vision Restoration in Neurofibromatosis – Donor RGC Response to Microenvironment
04.05.2024 |
Stem Cell Derived RGCs – Improving the Success of Transplantation Strategies – Phase B
04.05.2024 |
Neuroprotection and Optic Nerve Regeneration in a Mouse NF1 OPG Model – Phase B
04.05.2024 |
NF1-OPG Pig Model Development
04.05.2024 |
Axon Regeneration and Vision Restoration in NF1-OPG – Phase B
04.05.2024 |
RGC Differentiation and Transplantation for NF1-OPG – Phase B
04.05.2024 |
Human iPSC-derived Reporter Lines for Optic Nerve Remyelination Research in NF1
04.05.2024 |
Generation and Neuroprotective Studies of NF1 Patient-derived RGCs – Phase B
03.27.2024
Detroit Future City Releases New Report: “Keeping Your Family Home: Addressing the Challenges of Inherited Properties in Detroit”
Read
